Search General Info
Search Education
Search Partnering Companies
Panelists will feature academics and industry thought leaders as they share their expertise in novel oncology drug discovery, development and commercialization as well as address the issues related to future strategies for unlocking the potential of checkpoint inhibitors, including the failure of some first generation targets and what new approaches might look like.
Moderator
EVP, Oncology Practice Head
Cello Health BioConsulting (Previously Defined Health)
Speakers
EVP, Oncology Practice Head
Cello Health BioConsulting (Previously Defined Health)
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
